The Pharmalagasy manufacturing unit launches the third model of
The Pharmalagasy plant launches the third variation of Covid Organics, the improved traditional remedy based on artemisia called CVO + Curative.
The clinical trial, performed on 339 patients for 15 days (+28 days of follow-up), was supported by the WHO – which also supports other clinical trials related to traditional medicine in Africa – and provides a curative effect up to 87.1%.
An exhibition that cannot hide the damage caused by the health crisis that the country has been going through for two years.
No one expected that. While the epidemic is experiencing a calmer, a last-minute email announces a “world prince” who will change Madagascar’s history and an “alternative solution for humanity”.
This is the launch of Curative CVO +, by the Pharmalagasy plant, 100% owned by the state of Madagascar. An improved remedy based on artemisia that will cure mild to moderate forms of Covid-19. Covid Organics was launched by Andry Rajoelina in April 2020, first as an herbal tea and then as a preventive capsule.
A year later, the Malagasy authorities continued to sign, while the government had to agree to subscribe to the Covax facility in late April ahead of the epidemic on the island that the cure did not spare.
Saturated hospitals, unpaid medical staff, lack of medical equipment or even a shortage of medicines … The lack of resources in the Malagasy health system has been widely criticized.
But the rehabilitation of the factory has cost a few billion arriary, according to its CEO Pierre Raoelina. Covid Organics herbal tea costs at least $ 1.43 million (5.44 billion dariary), according to information available on the website of the Ministry of Economy and Finance.